Suppr超能文献

外周 5-HT₁D 和 5-HT₇ 血清素能受体调节慢性沙格雷酯治疗大鼠的交感神经递质传递。

Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.

机构信息

Laboratorio de Farmacología, Departamento de Fisiología y Farmacología, Facultad de Farmacia, Universidad de Salamanca, 37007 Salamanca, Spain.

出版信息

Eur J Pharmacol. 2013 Aug 15;714(1-3):65-73. doi: 10.1016/j.ejphar.2013.05.045. Epub 2013 Jun 11.

Abstract

5-HT₂ receptor activation induces vasoconstriction, hypertension and platelet aggregation; therefore, its blocking may be useful in cardiovascular diseases, probably due to alterations in the modulation of serotonergic system. The aim of this study was to evaluate whether 5-HT₂ receptor blockade changes serotonergic modulation of sympathetic neurotransmission in pithed rats. Serotonergic modulation of sympathetic neurotransmission was investigated in Wistar rats treated with sarpogrelate, a 5-HT₂ receptor antagonist, during 14 days (30 mg/kg/day). After central nervous system destruction, we conducted electrical stimulation throughout the spinal cord flow to study the 5-HT-related products action on adrenergic system. 5-Hydroxytryptamine exerted inhibition of sympathetic outflow in sarpogrelate-treated pithed rats. This effect was mimicked and enhanced by 5-CT (5-HT₁/₇ receptor agonist). L-694,247 and AS-19, 5-HT₁D and 5-HT₇ receptor agonists respectively, reproduced this action. Pretreatment with LY310762+SB258719 (5-HT₁D and 5-HT₇ receptor antagonists, respectively) completely abolished 5-CT inhibitory action. The nature of this action was prejunctional since these agonists did not modify the pressor responses induced by exogenous noradrenaline. Western Blot analysis confirmed a higher expression of 5-HT₁D receptors in sarpogrelate-treated rats. Experimental 5-HT₂ receptor blockade induces changes in the 5-HT receptors involved in the serotonergic inhibition of sympathetic-induced pressor responses. Prejunctional activation of 5-HT₁D and 5-HT₇ receptors induces a significantly higher serotonergic inhibition on adrenergic neurotransmission in sarpogrelate-treated pithed rats. The antagonism of 5-HT₂ receptors produces an enhancement of serotonergic sympathoinhibitory effect, which may explain the beneficial effects of this blockade in cardiovascular disorders where 5-hydroxytryptamine plays a crucial role.

摘要

5-HT₂ 受体激活可引起血管收缩、高血压和血小板聚集;因此,其阻断可能对心血管疾病有益,这可能是由于 5-羟色胺能系统调节的改变。本研究旨在评估 5-HT₂ 受体阻断是否会改变电刺激麻醉大鼠脊髓引起的交感神经递质传递的 5-羟色胺能调制。在给予 5-HT₂ 受体拮抗剂沙格雷酯(30mg/kg/天)治疗 14 天后,研究了 5-羟色胺能调制对交感神经递质传递的影响。在中枢神经系统破坏后,我们通过脊髓流进行电刺激,以研究 5-羟色胺相关产物对肾上腺素能系统的作用。5-羟色胺对沙格雷酯治疗的电刺激麻醉大鼠的交感神经传出产生抑制作用。5-CT(5-HT₁/₇受体激动剂)模拟并增强了这种作用。5-HT₁D 和 5-HT₇ 受体激动剂 L-694,247 和 AS-19 分别复制了这种作用。LY310762+SB258719(5-HT₁D 和 5-HT₇ 受体拮抗剂)预处理完全消除了 5-CT 的抑制作用。这种作用的性质是节前的,因为这些激动剂不会改变外源性去甲肾上腺素引起的升压反应。Western Blot 分析证实沙格雷酯治疗大鼠 5-HT₁D 受体表达增加。实验性 5-HT₂ 受体阻断可引起参与 5-羟色胺抑制交感神经引起的升压反应的 5-HT 受体发生变化。5-HT₁D 和 5-HT₇ 受体的节前激活可显著增加沙格雷酯治疗的电刺激麻醉大鼠 5-羟色胺对肾上腺素能神经递质传递的抑制作用。5-HT₂ 受体拮抗剂产生的 5-羟色胺抑制作用增强可能解释了这种阻断在心血管疾病中的有益作用,在心血管疾病中 5-羟色胺起着至关重要的作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验